Clinical Trial

A Study of Factors Influencing Recurrence After Thermal Ablation of Papillary Thyroid Carcinoma

Recruiting
View on ClinicalTrials.gov →
Summary
A prospective cohort of papillary thyroid carcinoma(PTC), patients who received thermal ablation in our hospital since February 2023 was established as the study object. Preoperative and postoperative demographic data, ultrasonography, other relevant laboratory tests, and thyroid disease-related scales such as fatigue, depression, and stress were collected. The influencing factors of PTC recurrence were analyzed.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2023-07-19.
Trial Details
NCT Number NCT05962892
Lead Sponsor Beijing Friendship Hospital
Conditions Papillary Thyroid Carcinoma, Thermal Ablation
Enrollment 600 participants
Start Date 2024-02-01
Primary Completion 2028-02-28 (estimated)
Study Completion 2028-02-28 (estimated)
Updated on ClinicalTrials.gov 2024-01-30